학술논문

Psychiatric research: psychoproteomics, degradomics and systems biology
Document Type
Report
Source
Expert Review of Proteomics. April 2008, Vol. 5 Issue 2, p293, 22 p.
Subject
Oncology, Experimental
Morphine
Brain
Psychiatric research
Schizophrenia
Methamphetamine
Cancer -- Research
Health
Language
English
ISSN
1478-9450
Abstract
While proteomics has excelled in several disciplines in biology (cancer, injury and aging), neuroscience and psychiatryproteomic studies are still in their infancy. Several proteomic studies have been conducted in different areas of psychiatric disorders, including drug abuse (morphine, alcohol and methamphetamine) and other psychiatric disorders (depression, schizophrenia and psychosis). However, the exact cellular and molecular mechanisms underlying these conditions have not been fully investigated. Thus, one of the primary objectives of this review is to discuss psychoproteomic application in the area of psychiatric disorders, with special focus on substance- and drug-abuse research. In addition, we illustrate the potential role of degradomic utility in the area of psychiatric research and its application in establishing and identifying biomarkers relevant to neurotoxicity as a consequence of drug abuse. Finally, we will discuss the emerging role of systems biology and its current use in the field of neuroscience and its integral role in establishing a comprehensive understanding of specific brain disorders and brain function in general.
Author(s): Firas H Kobeissy [sup.[[dagger]]] [sup.1] , Shankar Sadasivan [sup.2] , Jing Liu [sup.3] , Mark S Gold [sup.4] , Kevin KW Wang [sup.[[dagger]]] [sup.5] Keywords: biomarkers; degradomics; drug of [...]